{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:43:50Z","timestamp":1774593830738,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY028739"],"award-info":[{"award-number":["R01 EY028739"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ophtha.2022.05.008","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T20:39:37Z","timestamp":1652733577000},"page":"1096-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database"],"prefix":"10.1016","volume":"129","author":[{"given":"Yuwei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Claire","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idara","family":"Akpandak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin F.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-6818","authenticated-orcid":false,"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2022.05.008_bib1","doi-asserted-by":"crossref","first-page":"E680","DOI":"10.1503\/cmaj.190178","article-title":"Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England","volume":"191","author":"Wu","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.ophtha.2022.05.008_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000573","article-title":"Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study","volume":"8","author":"Irving","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002024","article-title":"Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study","volume":"13","author":"Fardet","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ophtha.2022.05.008_bib4","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jaad.2020.07.089","article-title":"Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak","volume":"83","author":"Veenstra","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ophtha.2022.05.008_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2021.06.006","article-title":"COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence","volume":"148","author":"Adir","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib7","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/bcp.14622","article-title":"Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: a Danish cohort study","volume":"87","author":"N\u00f8rg\u00e5rd","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib8","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2665-9913(21)00325-8","article-title":"Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative","volume":"4","author":"Andersen","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib9","doi-asserted-by":"crossref","first-page":"e4124","DOI":"10.1093\/cid\/ciaa1488","article-title":"Association between chronic use of immunosuppresive drugs and clinical outcomes from Coronavirus Disease 2019 (COVID-19) hospitalization: a retrospective cohort study in a large US health system","volume":"73","author":"Andersen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/annrheumdis-2020-218580","article-title":"SARS CoV-2 infection among patients using immunomodulatory therapies","volume":"80","author":"Winthrop","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.26028","article-title":"Disease-modifying therapies and Coronavirus Disease 2019 severity in multiple sclerosis","volume":"89","author":"Sormani","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2020-217984","article-title":"Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Freites Nu\u00f1ez","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib14","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","article-title":"Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.41619","article-title":"COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study","volume":"73","author":"D\u2019Silva","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"80","author":"Strangfeld","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2021.10.007","article-title":"The association between non-infectious uveitis and COVID-19 outcomes : an analysis of United States claims-based data","volume":"129","author":"Miller","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.05.008_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjophthalmol-2020-316776","article-title":"Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic","volume":"105","author":"Agrawal","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib19","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.ophtha.2020.05.037","article-title":"Managing uveitis during the COVID-19 pandemic","volume":"127","author":"Smith","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.05.008_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41433-020-0905-1","article-title":"Implications of COVID-19 for uveitis patients: perspectives from Hong Kong","volume":"34","author":"Hung","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2022.05.008_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bjophthalmol-2020-316586","article-title":"COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs","volume":"105","author":"Thng","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib22","unstructured":"OptumLabs. OptumLabs and OptumLabs Data Warehouse (OLDW) Descriptions and Citation 2018 Edition. Cambridge, MA: OptumLabs."},{"key":"10.1016\/j.ophtha.2022.05.008_bib23","author":"Keisler-Starkey"},{"key":"10.1016\/j.ophtha.2022.05.008_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/pds.1549","article-title":"Using prescription registries to define continuous drug use: how to fill gaps between prescriptions","volume":"17","author":"Nielsen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ophtha.2022.05.008_bib26","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/archinternmed.2008.506","article-title":"Comparative effectiveness of different \u03b2-adrenergic antagonists on mortality among adults with heart failure in clinical practice","volume":"168","author":"Go","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ophtha.2022.05.008_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A\u00a0practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00001648-199403000-00006","article-title":"Some statistical considerations in the analysis of case-control studies when the exposure variables are continuous measurements","volume":"5","author":"Robertson","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.ophtha.2022.05.008_bib29","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2022.05.008_bib30","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","article-title":"Treatment benefit or survival of the fittest: What drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?","volume":"70","author":"Strangfeld","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105950","article-title":"Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials","volume":"77","author":"Yang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chest.2015.12.018","article-title":"Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids","volume":"149","author":"Simpson","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ophtha.2022.05.008_bib33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ophtha.2022.05.008_bib34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ophtha.2022.05.008_bib35","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.ophtha.2022.05.008_bib36","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1097\/CCM.0000000000004093","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis","author":"Lansbury","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ophtha.2022.05.008_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/acr2.11221","article-title":"Autoimmune and chronic inflammatory disease patients with COVID-19","volume":"3","author":"Ungaro","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ecco-jcc\/jjaa215","article-title":"Clinical outcomes of Covid-19 in patients with inflammatory bowel disease: a nationwide cohort study","volume":"15","author":"Derikx","year":"2021","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/BOR.0000000000000725","article-title":"Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases","volume":"32","author":"Gianfrancesco","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib40","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2022.05.008_bib41","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2020.10.007","article-title":"Factors associated with adverse COVID-19 outcomes in patients with psoriasis\u2014insights from a global registry\u2013based study","volume":"147","author":"Mahil","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib43","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/annrheumdis-2021-219845","article-title":"Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study","volume":"80","author":"Bower","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2022.05.008_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-\u03b1 induced by SARS-coronavirus spike protein in murine macrophages via NF-\u03baB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.ophtha.2022.05.008_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109935","article-title":"IL-17A and TNF-\u03b1 as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19","volume":"144","author":"Leija-Mart\u00ednez","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ophtha.2022.05.008_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the inflammatory response to severe COVID-19 Illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ophtha.2022.05.008_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2020-001439","article-title":"Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?","volume":"7","author":"Santos","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.ophtha.2022.05.008_bib48","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S2665-9913(20)30120-X","article-title":"The immunology of COVID-19: is immune modulation an option for treatment?","volume":"2","author":"Zhong","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib49","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2147\/CLEP.S256735","article-title":"Statistical analysis of clinical COVID-19 data: a concise overview of lessons learned, common errors and how to avoid them","volume":"12","author":"Wolkewitz","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib50","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2022.05.008_bib51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.05.008_bib52","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2020.20323","article-title":"Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations","volume":"324","author":"Kadri","year":"2020","journal-title":"JAMA"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:13:14Z","timestamp":1758982394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642022003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0161642022003621"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.05.008","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}